<DOC>
	<DOCNO>NCT01035853</DOCNO>
	<brief_summary>The purpose study determine whether nasal inhalation Colistin effective decrease Pseudomonas aeruginosa bacterial count nasal lavage fluid .</brief_summary>
	<brief_title>Sino-nasal Inhalation Colistin Patients With Cystic Fibrosis Pseudomonas Aeruginosa Colonization</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pseudomonas Infections</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<criteria>subject confirm diagnosis cystic fibrosis detection P. aeruginosa nasal lavage ( culture ) chronic P.a . colonization lung ( day 28 ) inform consent patient parent subject &gt; = 6 year subject able comply inhalation procedure nasal lavage procedure schedule protocol woman childbearing potential include study , use effective method birth control protocol subject critical condition define : forced expiratory volume one second &lt; 30 % / arterial oxygen saturation &lt; 93 % without O2substitution ; need O2substitution subject ear , nose , throat surgery within 3 month prior study subject show sign nasal bleed subject ear drum perforation subject acute rhinosinusitis pulmonary exacerbation study entry need additional systemic antibiotic therapy pseudomonas aeruginosa subject unlikely comply procedure schedule protocol subject know allergic reaction medication subject pregnant breastfeeding subject participate another clinical trial within 30 day prior study entry 30 day end study . systemic ( oral intravenous ) antibiotic treatment P.a . 14 day prior inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>